Genetic and environmental risk assessment for colorectal cancer risk in primary care practice settings: A pilot study

Genetics in Medicine

Volumn 9, Issue 6, 2007, Pages 378-384

  Myers, Ronald E ^a   Weinberg, David S ^b   Manne, Sharon L ^b   Sifri, Randa ^a   Cocroft, James ^a   Kash, Kathryn ^a   Wilfond, Benjamin ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL PRACTICE; COLORECTAL CANCER; CONTROLLED STUDY; DECISION MAKING; ENVIRONMENTAL FACTOR; ERYTHROCYTE; FEMALE; GENETIC COUNSELING; GENETIC RISK; HUMAN; MALE; NURSE; PHYSICIAN; PRIMARY MEDICAL CARE; RISK ASSESSMENT; SOCIAL SUPPORT; UNIVARIATE ANALYSIS;

AGED; COLORECTAL NEOPLASMS; ENVIRONMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PRIMARY HEALTH CARE; RISK ASSESSMENT;

EID: 34250744155     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3180654ce2     Document Type: Article

References (26)

1. Collins FS. Shattuck lecture-medical and societal consequences of the Human Genome Project. N Engl J Med 1999;341:28-37.
2. Khoury MJ, Yang Q, Gwinn M, et al. An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genet Med 2004;6:38-47.
3. Marteau TM, Lerman C. Genetic risk and behavioural change. BMJ 2001; 322:1056-9.
4. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998;129: 517-524.
5. Keku T, Millikan R, Worley K, Winkel S, et al. 5,10- Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prevent 2002;11:1611-1621.
6. Chen C, Ma J, Stampfer MJ, Palomeque C, et al. Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics (2002);12:339-342.
7. Chen J, Giovannucci E, Hunter D.MTHFRpolymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: An example of gene-environment interactions in colorectal tumorigenesis. J Nutr 1999; 129: 560S-564S.
8. Lieberman D. Screening for colorectal cancer in average-risk populations. Am J Med 2006;119:728-35.
9. Weinberg DS, Turner BJ, Wang H, Myers RE, et al. A survey of women regarding factors affecting colorectal cancer screening compliance. Prev Med 2004;38:669-675.
10. Myers RE. Decision counseling in cancer prevention and control. Health Psychol 2005;24(Supplement4 suppl):S71-S77.
11. Vernon SW, Myers RE, Tilley BC. Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev 1997;6:825-832.
12. Tiro JA, Vernon SW, Hyslop T Myers RE. Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 2005;14:2855-2861.
13. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 2006;56:11-25.
14. Weiss D, Marmar C. The impact of event scale-revised. In: Wilson JP, Keane TM, editors. Assessing psychological trauma and PTSD. New York: Guilford Press; 1997: 577.
15. Wilfond BS, Fost N. The cystic fibrosis gene: medical and social implications for heterozygote detection. JAMA 1990;263:2777-2783.
16. Masny A, Daly M, Ross E, Balshem A, et al. A training course for oncology nurses in familial cancer risk assessment: evaluation of knowledge and practice. J Cancer Educ 2003;18:20-25.
17. Wilson BJ. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions. Health Technol Assess 2005;9:1-126.
18. Burke W. Genetic testing in primary care. Annu Rev Genomics Hum Genet 2004;5: 1-14.
19. Wang C, Gonzalez R, Merajver SD. Assessment of genetic testing and related counseling services: current research and future directions. Soc Sci Med 2004;58:1427-1442.
20. Burke W, Acheson L, Botkin J, Bridges K, et al. Genetics in primary care: a USA faculty development initiative. Community Genet 2002;5:138-146.
21. Smith KR, Croyle RT. Attitudes toward genetic testing for colon cancer risk. Am J Public Health 1995;85:1435-1438.
22. Andrykowski MA, Munn RK, Studts JL. Interest in learning of personal genetic risk for cancer: a general population survey. Prev Med 1996;25:527-536.
23. Graham ID, Logan DM, Hughes-Benzie R, et al. How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey. Cancer Prev Control 1998;2:167-172.
24. Satia JA, McRitchie S, Kupper LL, Halbert CH. Genetic testing for colon cancer among African-Americans in North Carolina. Prev Med 2006;42:51-59.
25. Lerman C, Gold K, Audrain J, Lin TH, et al. Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol 1997;16:87-99.
26. Audrain J, Boyd NR, Roth J, Main D, et al. Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. Addict Behav 1997; 22:741-751.